丹娜生物
(920009)
| 流通市值：3.18亿 | | | 总市值：24.43亿 |
| 流通股本：1008.00万 | | | 总股本：7754.60万 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 187,384,210.88 | 118,141,959.57 | 54,035,723.96 | 242,282,883.91 |
| 营业总成本 | 120,000,307.54 | 77,330,665.63 | 36,561,854.44 | 153,730,093.27 |
| 其他经营收益 | | | | |
| 营业利润 | 77,733,464.82 | 47,214,406.25 | 20,211,076.99 | 110,909,336.88 |
| 利润总额 | 81,079,719.93 | 50,514,365.08 | 20,209,916.62 | 110,665,027.84 |
| 净利润 | 72,839,933.05 | 45,906,554.77 | 18,321,517.76 | 97,742,993.21 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 72,839,933.05 | 45,906,554.77 | 18,321,517.76 | 97,742,993.21 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 536,035,669.2 | 549,451,074.8 | 562,790,331.55 | 559,004,050.04 |
| 非流动资产: | | | | |
| 非流动资产合计 | 210,327,762.81 | 195,782,355.78 | 184,764,479.51 | 184,915,596.98 |
| 资产总计 | 746,363,432.01 | 745,233,430.58 | 747,554,811.06 | 743,919,647.02 |
| 流动负债: | | | | |
| 流动负债合计 | 42,752,207.37 | 42,798,296.22 | 41,230,026.86 | 55,554,257.04 |
| 非流动负债: | | | | |
| 非流动负债合计 | 7,512,367.5 | 6,261,330.61 | 10,173,792.57 | 10,668,691.22 |
| 负债合计 | 50,264,574.87 | 49,059,626.83 | 51,403,819.43 | 66,222,948.26 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 696,098,857.14 | 696,173,803.75 | 696,150,991.63 | 677,696,698.76 |
| 股东权益合计 | 696,098,857.14 | 696,173,803.75 | 696,150,991.63 | 677,696,698.76 |
| 负债和股东权益合计 | 746,363,432.01 | 745,233,430.58 | 747,554,811.06 | 743,919,647.02 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 207,614,074.04 | 130,263,556.74 | 57,231,370.67 | 302,042,796.52 |
| 经营活动现金流出小计 | 156,273,374.3 | 104,987,109.27 | 58,412,142.25 | 195,459,950.7 |
| 经营活动产生的现金流量净额 | 51,340,699.74 | 25,276,447.47 | -1,180,771.58 | 106,582,845.82 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,351,589,808.25 | 1,056,168,533.52 | 442,990,860.72 | 3,038,695,678.24 |
| 投资活动现金流出小计 | 1,655,913,925.17 | 1,185,199,081.67 | 602,290,188.45 | 3,191,866,741.64 |
| 投资活动产生的现金流量净额 | -304,324,116.92 | -129,030,548.15 | -159,299,327.73 | -153,171,063.4 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | 136,800,000 |
| 筹资活动现金流出小计 | 55,983,778.34 | 28,441,578.52 | 0 | 20,893,926.25 |
| 筹资活动产生的现金流量净额 | -55,983,778.34 | -28,441,578.52 | 0 | 115,906,073.75 |
| 汇率变动对现金及现金等价物的影响 | -171,079.76 | -121,633.15 | -35,995.75 | -157,655.03 |
| 现金及现金等价物净增加额 | -309,138,275.28 | -132,317,312.35 | -160,516,095.06 | 69,160,201.14 |
| 期末现金及现金等价物余额 | 35,050,021.59 | 211,870,984.52 | 183,672,201.81 | 344,188,296.87 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -132,317,312.35 | - | 69,160,201.14 |